EDAP TMS SA (EDAP): יחס שווי פעילות לרווח לפני ריבית, מסים ופחת
The EV/EBITDA multiple price visualization for EDAP TMS S.A. (EDAP) is fixed at 0.00. The company's management is promoting ultrasound robotics for prostate therapy, expanding insurance access within the United States. The business relies on patent protection for Focal One systems, creating high barriers for clinics to switch to alternative solutions. Simultaneously, the company is implementing environmental standards, reducing production waste and optimizing energy consumption across its workshops.
פילוחי מדדים מקיפים ואנליטיקה עבור edap-tms.com (EDAP)
The technological leadership of EDAP TMS S.A. (EDAP) in the production of medical ultrasound systems in France requires significant capital expenditures, making EV/EBITDA a key tool for business valuation accounting for net debt. By analyzing the trend level of the company's EV/EBITDA, an investor determines the ratio of market capitalization to operating profit, where current price action reflects the market consensus regarding the future efficiency of high-precision assembly lines.
